Position in NUVB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$481,209
+$354,408 QoQ
Shares Held
112,170
+692.6% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPSTONE INVESTMENT ADVISORS, LLC holds $29,070,840 across 29 Biotechnology names. NUVB ranks #8 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
250,000 | $10,057,500 | |
| 2 | DAWN |
Day One Biopharmaceuticals, Inc.
|
236,000 | $5,059,840 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
265,730 | $3,842,455 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,895 | $1,739,273 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
29,061 | $813,998 | |
| 6 | RPRX |
Royalty Pharma plc
|
14,481 | $694,653 | |
| 7 | ACAD |
Acadia Pharmaceuticals Inc
|
22,735 | $506,081 | |
| 8 | NUVB |
Nuvation Bio Inc.
This page
|
112,170 | $481,209 |
All Filings in NUVB
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $481,209 | 112,170 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $126,801 | 14,152 | Shares | Defined | 2026-02-17 | |
| 2021-03-31 | $296,132 | 28,338 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||